Prognostic and Safety Implications of Renin-Angiotensin-Aldosterone System Inhibitors in Hypertrophic Cardiomyopathy: A Real-World Observation Over 2,000 Patients.

MLA

Park, Chan Soon, et al. “Prognostic and Safety Implications of Renin-Angiotensin-Aldosterone System Inhibitors in Hypertrophic Cardiomyopathy: A Real-World Observation Over 2,000 Patients.” Korean Circulation Journal, vol. 53, no. 9, Sept. 2023, pp. 606–18. EBSCOhost, https://doi.org/10.4070/kcj.2023.0035.

APA

Park, C. S., Rhee, T.-M., Lee, H. J., Yoon, Y. E., Park, J.-B., Lee, S.-P., Kim, Y.-J., Cho, G.-Y., Hwang, I.-C., & Kim, H.-K. (2023). Prognostic and Safety Implications of Renin-Angiotensin-Aldosterone System Inhibitors in Hypertrophic Cardiomyopathy: A Real-World Observation Over 2,000 Patients. Korean Circulation Journal, 53(9), 606–618. https://doi.org/10.4070/kcj.2023.0035

Chicago

Park, Chan Soon, Tae-Min Rhee, Hyun Jung Lee, Yeonyee E Yoon, Jun-Bean Park, Seung-Pyo Lee, Yong-Jin Kim, Goo-Yeong Cho, In-Chang Hwang, and Hyung-Kwan Kim. 2023. “Prognostic and Safety Implications of Renin-Angiotensin-Aldosterone System Inhibitors in Hypertrophic Cardiomyopathy: A Real-World Observation Over 2,000 Patients.” Korean Circulation Journal 53 (9): 606–18. doi:10.4070/kcj.2023.0035.